We're delighted we can offer this prize for the second year running.

Building on from last year where Re-Vana Therapeutics delivered an outstanding pitch to take first prize, I'm excited to see more fantastic innovations and companies/researchers with the ideas to help restore or preserve vision for patients.

It's a passion of mine to help these companies and give recognition to the people behind the next generation of therapies.

James Bojdo, PhD

CEO & Co-Founder, Medinect Ophtho

Re-Vana win first prize for their pitch for

Congratulations to Suil Pharma, acheoveing

ChatGPT Image Mar 24, 2026 at 11_10_03 PM.png

RetInnovate Pitch Competition – Prize Terms & Conditions

1. Overview. The prizes will be awarded to the winners of the RetInnovate Pitch Competition, held online during the week commencing ...... The prize is in the form of a voucher redeemable against the cost of one preclinical study or project with MediNect Bioservices Ltd ("MediNect").

2. Eligibility. The competition is open to companies or teams developing therapeutic or related biomedical innovations, including those at the concept, preclinical, translational, or early clinical stages. Entrants must be legally registered entities, or affiliated with a legally registered entity, and must agree to:-

Participate in the online pitch event (date confirmed at event)
Engage in follow-up communication if selected as the winner

3. Judging Criteria. Pitches will be evaluated by an independent panel of judges with experience across investment, pharma, and biotech. The judging panel will assess entries based on several criteria relating to invest-ability, including:

Scientific and technical merit of the concept
Size and attractiveness of the addressable market
Route to market and development feasibility

The panel’s decision is final and no correspondence will be entered into. Feedback will be given to each entry with pointers to improve. The criteria will not be based on how advanced the technology/company is.

4. Prize Details. The prize pool is a total of £40,000 service credit (the "Voucher"), with 1st prize of £25,000, second prize £15,000 and third prize £10,000 to be applied exclusively towards the cost of one preclinical project or study delivered by MediNect Bioservices Ltd at a minimum cost of £32,000.

The Voucher:

Cannot be exchanged for cash
Cannot be split across multiple projects
Cannot be transferred to another company or third party
Must be used within 12 months of the award date

The value will be applied against a mutually agreed scope of work defined under a separate project agreement with MediNect. Any project costs exceeding the voucher value will be the responsibility of the winner.

5. Intellectual Property All intellectual property (IP) generated as part of the pitched project remains solely with the winning company. Participation in the competition and use of the voucher does not transfer, assign, or otherwise affect any existing or future IP rights held by the winner.

6. Publicity and Promotion The winning team may be announced publicly by RetInnovate and MediNect, including name, logo, and non-confidential summary of the project/pitch with the agreement from the winning innovator/company. Winners may be asked to participate in promotional activity related to the award (e.g., press release, testimonial, follow-up interview).

7. General Conditions MediNect reserves the right to reject any scope of work that falls outside its service capabilities or regulatory constraints. RetInnovate and MediNect shall not be liable for any loss, damage, or delay resulting from force majeure or factors beyond their control. RetInnovate reserves the right to amend these Terms & Conditions at any time without prior notice, provided the core value and intent of the prize remains unchanged.

For further information about the competition or the prize redemption process, please contact: enquiries@flowcoevents.com

Participants of RetInnovate 2026 have the opportunity to pitch in front of investors, gain feedback and have the chance to be awarded to £25,000 from our main sponsor Medinect Ophtho Bioservices Ltd